Bioelectronic Sensor Technology for Detection of Cystic Fibrosis and Hereditary Hemochromatosis Mutations

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 12, 2003, Pages 1565-1572

  Bernacki, Susan H ^a   Farkas, Daniel H ^b,k   Shi, Wenmei ^b   Chan, Vivian ^b,l   Liu, Yenbou ^b   Beck, Jeanne C ^c   Bailey, Karen Snow ^d,m   Pratt, Victoria M ^e,n   Monaghan, Kristin G ^f   Matteson, Karla J ^g   Schaefer, Frederick V ^h   Friez, Michael ⁱ   Shrimpton, Antony E ^j   Stenzel, Timothy T ^a,o  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MOTOROLA INC   (United States)

^c Laboratory of Molecular and Cellular Biology of Hematopoiesis   (United States)

^d MAYO CLINIC   (United States)

^e LABORATORY CORPORATION OF AMERICA   (United States)

^f HENRY FORD HOSPITAL   (United States)

^g UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^h Chapman Inst of Medical Genetics   (United States)

ⁱ GREENWOOD GENETIC CENTER   (United States)

^j SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

^l STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m AUCKLAND CITY HOSPITAL   (New Zealand)

ⁿ QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^o ABBOTT LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; BIOSENSOR; CELL LINE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC TEST; EPSTEIN BARR VIRUS; GENE; HEMOCHROMATOSIS; HFE GENE; HUMAN; HUMAN CELL; LYMPHOCYTE; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PERFORMANCE; TECHNOLOGY; VALIDATION PROCESS;

BASE SEQUENCE; BIOSENSING TECHNIQUES; BIOTECHNOLOGY; CELL LINE, TRANSFORMED; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; ELECTRONICS; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 0344737857     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. McGlennen RC. Miniaturization technologies for molecular diagnostics. Clin Chem. 2001;47:393-402.
2. Farkas DH. Bioelectronic DNA chips for the clinical laboratory. Clin Chem. 2001;47:1871-1872.
3. Umek RM, Lin SS, Chen Y-P, et al. Bioelectronic detection of point mutations using discrimination of the H63D polymorphism of the Hfe gene as a model. Mol Diagn. 2000;5:321-328.
4. Umek RM, Lin SW, Vielmetter J, et al. Electronic detection of nucleic acids: a versatile platform for molecular diagnostics. J Mol Diagn. 2001;3:74-84.
5. Yu CJ, Wan Y, Yowanto H, et al. Electronic detection of single-base mismatches in DNA with ferrocene-modified probes. J Am Chem Soc. 2001;123: 11155-11161.
6. Yu CJ, Wang H, Wan Y, et al. 2′-Ribose-ferrocene oligonucleotides for electronic detection of nucleic acids. J Organic Chem. 2001;66:2937-3942.
7. Stenzel TT, Bernacki SH, Beck JC, et al. Establishment of stably transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing. Am J Hum Genet. 2001;69: 438.
8. Stenzel TT, Bernacki SH, Beck JC, et al. Use of residual clinical blood samples to establish stable EBV transformed cell lines for PE/QA of molecular genetic testing. Genet Med. 2002;4:212.
9. Williams LO, Cole EC. General Recommendations for Quality Assurance Programs for Laboratory Molecular Genetic Tests, Final Monograph. Atlanta, Ga: Centers for Disease Control and Prevention, Public Health Practice Program Office, Division of Laboratory Services; 1999. Available at: http://www.phppo.cdc.gov/dls/pdf/genetics/dyncor.pdf. Accessed September 4, 2003.
10. Williams LO, Cole EC, Lubin IM, Iglesias NI, Jordan RL, Elliott LE. Quality assurance in human molecular genetics testing: status and recommendations. Arch Pathol Lab Med. 2003;127:1353-1358.
11. Louie LG, King MC. A novel approach to establishing permanent lymphoblastoid cell lines: Epstein-Barr virus transformation of cryopreserved lymphocytes. Am J Hum Genet. 1991;48:637-638.
12. Beck JC, Beiswanger CM, John EM, Satariano E, West D. Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies. Cancer Epidemiol Biomarkers Prev. 2001;10:551-554.
13. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245: 1066-1073.
14. Richards CS, Bradley LA, Amos J, et al. Standards and guidelines for CFTR mutation testing [published correction appears in GenetMed. 2002;4:471]. Genet Med. 2002;4:379-391.
15. Richards CS, Bradley LA, Amos J, et al. Standards and guidelines for CFTR mutation testing [published correction appears in GenetMed. 2002;4:471]. Genet Med. 2002;4:379-391.
16. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ, for the Subcommittee on Cystic Fibrosis Screening, Accreditation of Genetic Services Committee, American College of Medical Genetics. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med. 2001;3:149-154.
17. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245:1073-1080.
18. Zielenski J, Bozon D, Kerem B, et al. Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics. 1991;10:229-235.
19. Macek M Jr, Mackova A, Hamosh A, et al. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet. 1997;60:1122-1127.
20. Gervais R, Dumur V, Rigot JM, et al. High frequency of the R117H cystic fibrosis mutation in patients with congenital absence of the vas deferens. N Engl J Med. 1993;328:446-447.
21. Kiesewetter S, Macek M Jr, Davis C, et al. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nature Genet. 1993;5:274-278.
22. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet. 1996;13: 399-408.
23. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood. 1999;93:2502-2505.
24. Molecular Diagnostics for the Clinical Laboratorian. Totowa, NJ: Humana Press; 1997.